Concerning PDAC, Sukeda et al. [47] observed not only an association between MCT1 overexpression in cancer cells with an extended OS and PFS but also a significant decrease in lymph node metastasis occurrence. Here, SLC16A1 is linked to metastatic malignant neoplasm in the lymph nodes.